Chemotherapy-associated hemorrhagic posterior reversible encephalopathy syndrome (PRES) with considerations for circle of Willis variants on cerebral blood flow and autoregulation: A case report

Bahadar S. Srichawla,Kendall Presti,Vincent Kipkorir,Idanis Berrios Morales
DOI: https://doi.org/10.1097/md.0000000000037250
IF: 1.6
2024-02-25
Medicine
Abstract:Hodgkin lymphoma is a type of lymphoma that originates in the lymphatic system. [ 1 ] Treatment modalities include chemotherapy, radiation therapy, and in refractory cases, hematopoietic stem cell transplantation. Although these treatments have shown significant efficacy in inducing remission and prolonging survival, they are not without complications. [ 2 ] Neurotoxicity is one of the rare but serious side effects of some chemotherapeutic agents, with presentations ranging from subtle cognitive changes to severe life-threatening conditions. [ 3 ] Posterior reversible encephalopathy syndrome (PRES) is a neurologic condition characterized by a myriad of symptoms, ranging from headache and visual disturbances to seizures and altered consciousness. PRES has been associated with various medications and systemic conditions, including chemotherapy. [ 4 ] The pathophysiology of this syndrome is not yet understood, although hypertension and endothelial dysfunction play a significant role. [ 5 ] We depict the unfortunate case of a 42-year-old woman with Hodgkin lymphoma, who after intensive chemotherapy, developed PRES leading to catastrophic neurological events, offering insight into the potential hazards of aggressive chemotherapeutic regimens. Furthermore, we hypothesize the influence of the circle of Willis variants and hemodynamic changes that may influence the heterogeneity and severity of the burden of hemispheric lesion in PRES. This case report was completed according to the CARE (CAse REport) Statement and Checklist. [ 6 ]
medicine, general & internal
What problem does this paper attempt to address?